The major vault protein is responsive to and interferes with interferon-γ-mediated STAT1 signals

The major vault protein (MVP) is the main component of vaults, large ribonucleoprotein particles implicated in the regulation of cellular signaling cascades and multidrug resistance. Here, we identify MVP as an interferon γ (IFN-γ)-inducible protein. Treatment with IFN-γ resulted in a significant upregulation of MVP promoter activity as well as mRNA and protein levels. Activation of MVP expression by IFN-γ involved transcriptional upregulation through the JAK/STAT pathway based on an interaction of STAT1 with an interferon-γ-activated site (GAS) within the proximal MVP promoter. Mutation of this site distinctly reduced basal as well as IFN-γ-stimulated MVP transcription. IFN-γ also significantly enhanced the translation rate of MVP. Ectopic MVP overexpression in the MVP-negative lung cancer cell model H65 led to a downregulation of three known IFN-γ-regulated genes, namely ICAM-1, CD13 and CD36. Additionally, presence of MVP in H65 cells blocked both basal and IFN-γ-induced ICAM-1 expression whereas downmodulation of endogenous MVP levels by shRNA enhanced IFN-γ-induced ICAM-1 expression in U373 glioblastoma cells. MVP-mediated IFN-γ insensitivity was accompanied by significantly reduced STAT1 phosphorylation at Y701 and diminished translocation of STAT1 into the nucleus. Summarizing, we identify MVP as an IFN-γ-responsive gene interfering with IFN-γ-activated JAK/STAT signals. These data further substantiate that the vault particle functions as a general interaction platform for cellular signaling cascades.

[1]  P. Schlag,et al.  YB-1 facilitates basal and 5-fluorouracil-inducible expression of the human major vault protein (MVP) gene , 2005, Oncogene.

[2]  B. N. Day,et al.  Expression and proteasomal degradation of the major vault protein (MVP) in mammalian oocytes and zygotes. , 2005, Reproduction.

[3]  V. Ling.  Faculty Opinions recommendation of Molecular characterization of human 4Ig-B7-H3, a member of the B7 family with four Ig-like domains. , 2005 .

[4]  T. Furukawa,et al.  Characterization of MVP and VPARP assembly into vault ribonucleoprotein complexes. , 2004, Biochemical and biophysical research communications.

[5]  E. Wiemer,et al.  The Major Vault Protein Is a Novel Substrate for the Tyrosine Phosphatase SHP-2 and Scaffold Protein in Epidermal Growth Factor Signaling* , 2004, Journal of Biological Chemistry.

[6]  C. Pirker,et al.  SP-transcription factors are involved in basal MVP promoter activity and its stimulation by HDAC inhibitors. , 2004, Biochemical and biophysical research communications.

[7]  V. Kickhoefer,et al.  Analysis of MVP and VPARP promoters indicates a role for chromatin remodeling in the regulation of MVP. , 2004, Biochimica et biophysica acta.

[8]  K. Schroder,et al.  Interferon- : an overview of signals, mechanisms and functions , 2004 .

[9]  E. Park,et al.  Curcumin Suppresses Janus Kinase-STAT Inflammatory Signaling through Activation of Src Homology 2 Domain-Containing Tyrosine Phosphatase 2 in Brain Microglia 1 , 2003, The Journal of Immunology.

[10]  Nicola Gebbia,et al.  STAT proteins: From normal control of cellular events to tumorigenesis , 2003, Journal of cellular physiology.

[11]  P. Sonneveld,et al.  Vaults: a ribonucleoprotein particle involved in drug resistance? , 2003, Oncogene.

[12]  P. Sonneveld,et al.  The vault complex , 2003, Cellular and Molecular Life Sciences CMLS.

[13]  Dirk Troost,et al.  Overexpression of the Human Major Vault Protein in Gangliogliomas , 2003, Epilepsia.

[14]  B. Neel,et al.  The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling. , 2003, Trends in biochemical sciences.

[15]  E. Condom,et al.  Lung resistance-related protein as a predictor of clinical outcome in advanced testicular germ-cell tumours , 2003, British Journal of Cancer.

[16]  V. Kickhoefer,et al.  Disruption of the murine major vault protein (MVP/LRP) gene does not induce hypersensitivity to cytostatics. , 2002, Cancer research.

[17]  K. Suprenant.  Vault ribonucleoprotein particles: sarcophagi, gondolas, or safety deposit boxes? , 2002, Biochemistry.

[18]  Zhenbao Yu,et al.  PTEN Associates with the Vault Particles in HeLa Cells* , 2002, The Journal of Biological Chemistry.

[19]  J. Darnell,et al.  Signalling: STATs: transcriptional control and biological impact , 2002, Nature Reviews Molecular Cell Biology.

[20]  C. Horvath,et al.  Mechanisms of Type I interferon cell signaling and STAT-mediated transcriptional responses. , 2002, The Mount Sinai journal of medicine, New York.

[21]  E. Wiemer,et al.  Up-Regulation of Drug Resistance-Related Vaults During Dendritic Cell Development1 , 2002, The Journal of Immunology.

[22]  Walter Berger,et al.  Overexpression of the human major vault protein in astrocytic brain tumor cells , 2001, International journal of cancer.

[23]  T. Taniguchi,et al.  The interferon system and interferon regulatory factor transcription factors -- studies from gene knockout mice. , 2001, Cytokine & growth factor reviews.

[24]  B. Williams,et al.  Functional classification of interferon‐stimulated genes identified using microarrays , 2001, Journal of leukocyte biology.

[25]  W. Berger,et al.  A small upstream open reading frame causes inhibition of human major vault protein expression from a ubiquitous mRNA splice variant , 2001, FEBS letters.

[26]  W. Walther,et al.  Cloning and initial analysis of the human multidrug resistance-related MVP/LRP gene promoter. , 2000, Biochemical and biophysical research communications.

[27]  W. Berger,et al.  Expression of the major vault protein LRP in human non‐small‐cell lung cancer cells: Activation by short‐term exposure to antineoplastic drugs , 2000, International journal of cancer.

[28]  S. Akira,et al.  STAT family of transcription factors in cytokine-mediated biological responses. , 2000, Cytokine & growth factor reviews.

[29]  K. Tarte,et al.  JAK2 tyrosine kinase inhibitor tyrphostin AG490 downregulates the mitogen‐activated protein kinase (MAPK) and signal transducer and activator of transcription (STAT) pathways and induces apoptosis in myeloma cells , 2000, British journal of haematology.

[30]  J. Baak,et al.  Increased expression of multidrug resistance related proteins Pgp, MRP1, and LRP/MVP occurs early in colorectal carcinogenesis. , 1999, Journal of clinical pathology.

[31]  G. Feng,et al.  Shp-2 Tyrosine Phosphatase Functions as a Negative Regulator of the Interferon-Stimulated Jak/STAT Pathway , 1999, Molecular and Cellular Biology.

[32]  B. Williams,et al.  Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays , 1998 .

[33]  A. Tessitore,et al.  Two gamma-interferon-activation sites (GAS) on the promoter of the human intercellular adhesion molecule (ICAM-1) gene are required for induction of transcription by IFN-gamma. , 1998, European journal of biochemistry.

[34]  J E Darnell,et al.  Epidermal growth factor-induced growth inhibition requires Stat1 activation. , 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[35]  V. Kickhoefer,et al.  Vaults Are Up-regulated in Multidrug-resistant Cancer Cell Lines* , 1998, The Journal of Biological Chemistry.

[36]  G. Giaccone,et al.  Broad distribution of the multidrug resistance-related vault lung resistance protein in normal human tissues and tumors. , 1996, The American journal of pathology.

[37]  L. Rome,et al.  Dictyostelium Vaults: Disruption of the Major Proteins Reveals Growth and Morphological Defects and Uncovers a New Associated Protein (*) , 1995, The Journal of Biological Chemistry.

[38]  M. Holtzman,et al.  Selective interaction of a subset of interferon-gamma response element-binding proteins with the intercellular adhesion molecule-1 (ICAM-1) gene promoter controls the pattern of expression on epithelial cells. , 1994, The Journal of biological chemistry.

[39]  N. Kedersha,et al.  Evidence that vault ribonucleoprotein particles localize to the nuclear pore complex. , 1993, Journal of cell science.

[40]  T. Wick,et al.  Human dermal microvascular endothelial but not human umbilical vein endothelial cells express CD36 in vivo and in vitro. , 1992, Journal of immunology.

[41]  K. Schroder,et al.  Interferon-gamma: an overview of signals, mechanisms and functions. , 2004, Journal of leukocyte biology.

[42]  W. Berger,et al.  Overexpression of Hsp27 in a human melanoma cell line: regulation of E-cadherin, MUC18/MCAM, and plasminogen activator (PA) system , 2003, Cell stress & chaperones.

[43]  B. Williams,et al.  Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[44]  I. Roninson,et al.  Activation of the LRP (lung resistance-related protein) gene by short-term exposure of human leukemia cells to phorbol ester and cytarabine. , 1998, Oncology research.

[45]  H. Hoogsteden,et al.  Cytokines and glucocorticoids modulate human bronchial epithelial cell peptidases. , 1998, Cytokine.